Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Interleukin-6 Found to Protect Brain Cells

By Biotechdaily staff writers
Posted on 20 Jan 2003
A study has found that the cytokine interleukin-6 (IL-6), linked in the immune system to the development of inflammatory conditions and malignant diseases, plays a very different role in the brain by protecting brain cells from degenerative diseases. More...
The study was published in the January 15, 2003, issue of the Journal of Neuroscience.

Investigators from the Mayo Clinic (Rochester, MN, USA) genetically engineered lines of mice with varying levels of IL-6 production. All were infected with a virus that causes a degenerative nerve disease. Animals with high levels of IL-6 were able to fight off the infection with little or no damage to nervous tissues, while those with low levels of IL-6 became severely ill or died. Only two of 23 (~9%) infected mice possessing IL-6 died. By comparison, 17 of 29 mice (~60%%) lacking IL-6 died after virus infection.

Senior author Dr. Moses Rodriquez, a researcher at the Mayo Clinic said, "One of the biggest challenges we face as a society is the eventual loss and degeneration of neurons from many causes, so identifying any factor that protects neurons or promotes their survival is an important step toward improving health as we age. Every disease that is a degenerative disease of the nervous system could potentially be amenable to some kind of treatment with a growth factor like IL-6 because its goal is to keep neurons alive.”



Related Links:
Mayo Clinic

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automatic CLIA Analyzer
Shine i6000
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.